9AT: PARKMAN HEALTHCARE PARTNERS LLC

other names

PARKMAN HEALTHCARE PARTNERS LLC

Adviser Profile

As of Date	03/28/2025
Adviser Type - Large advisory firm
Number of Employees	12 50%
of those in investment advisory functions	8 60%
Registration	SEC, Approved, 03/15/2019

AUM^*	1,219,814,939 106%
of that, discretionary	1,219,814,939 106%
Private Fund GAV^*	468,990,879 29%
Avg Account Size	152,476,867 29%
SMA’s	No
Private Funds	4 2
Contact Info	(20 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Fund Type	Count	GAV
Fund TypeHedge Fund	Count3	GAV$464,926,609
Fund TypePrivate Equity Fund	Count1	GAV$4,064,270

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser VALENCE8	Hedge Fund1.1b	Liquidity Fund-	Private Equity Fund209.0m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.3b	AUM1.4b	#Funds17
Adviser SYCALE ADVISORS	Hedge Fund1.2b	Liquidity Fund-	Private Equity Fund37.3m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.2b	AUM512.7m	#Funds9
Adviser WHITEFORT CAPITAL MANAGEMENT, LP	Hedge Fund765.1m	Liquidity Fund-	Private Equity Fund7.5m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV772.6m	AUM772.6m	#Funds5
Adviser ALLIANCE ADVISORY & SECURITIES, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM639.4m	#Funds-
Adviser SUPERSTRING CAPITAL MANAGEMENT LP	Hedge Fund177.1m	Liquidity Fund-	Private Equity Fund31.0m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV208.1m	AUM218.3m	#Funds5
Adviser FERNWOOD INVESTMENT MANAGEMENT, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM435.7m	#Funds-
Adviser LAGO ASSET MANAGEMENT	Hedge Fund333.3m	Liquidity Fund-	Private Equity Fund69.3m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV402.6m	AUM457.3m	#Funds14
Adviser FORAGER CAPITAL MANAGEMENT, LLC	Hedge Fund332.6m	Liquidity Fund-	Private Equity Fund12.1m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV344.7m	AUM355.1m	#Funds2
Adviser X-SQUARE CAPITAL	Hedge Fund67.2m	Liquidity Fund-	Private Equity Fund218.1m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV285.3m	AUM616.9m	#Funds3
Adviser SEGRA CAPITAL MANAGEMENT, LLC	Hedge Fund459.6m	Liquidity Fund-	Private Equity Fund73.0m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund30.3m	Total Private Fund GAV562.9m	AUM532.6m	#Funds7

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker46090E103	Stock NameINVESCO QQQ TR (PUT)	$ Position$48,029,600	% Position5.00%	$ Change	# Change
Stck Ticker45784P101	Stock NameINSULET CORP	$ Position$35,886,158	% Position4.00%	$ Change8.00%	# Change10.00%
Stck Ticker101137107	Stock NameBOSTON SCIENTIFIC CORP	$ Position$42,408,227	% Position4.00%	$ Change39.00%	# Change53.00%
Stck Ticker02043Q107	Stock NameALNYLAM PHARMACEUTICALS INC	$ Position$39,986,640	% Position4.00%	$ Change33.00%	# Change-5.00%
Stck TickerG52694109	Stock NameKINIKSA PHARMACEUTICALS INTL	$ Position$26,077,917	% Position3.00%	$ Change93.00%	# Change37.00%
Stck Ticker126650100	Stock NameCVS HEALTH CORP	$ Position$28,609,450	% Position3.00%	$ Change-20.00%	# Change-27.00%
Stck Ticker92790C104	Stock NameVIRIDIAN THERAPEUTICS INC	$ Position$24,913,829	% Position3.00%	$ Change37.00%	# Change-11.00%
Stck Ticker98956P102	Stock NameZIMMER BIOMET HOLDINGS INC	$ Position$24,764,870	% Position3.00%	$ Change13.00%	# Change5.00%
Stck Ticker98422E103	Stock NameXERIS BIOPHARMA HOLDINGS INC	$ Position$14,584,226	% Position2.00%	$ Change48.00%	# Change-15.00%
Stck TickerN90064101	Stock NameUNIQURE NV	$ Position$20,158,430	% Position2.00%	$ Change226.00%	# Change-22.00%

Brochure Summary

Overview

A. Parkman Healthcare Partners LLC (the “Adviser” or “Parkman”) was formed in November 2018 as a Delaware limited liability company and has its principal place of business in Stamford, Connecticut. The principal owner of Parkman is Greg Martinez (the “Principal”), who has the overall responsibility for the day-to-day supervision and management of Parkman’s business. Parkman acts as the investment manager for: (i) a sponsored master-feeder structure (the “Fund”), a sponsored special purpose vehicle (the “SPV”); and (iii) sub-advised accounts (each a “Managed Account”, which, collectively with the Fund and SPV, are referred to as the “Clients”)).1 The Fund and SPV are for sophisticated, qualified investors (“Investors”). B. Parkman pursues its investment strategy through managing its Clients. Parkman has discretion with respect to investment decisions made for the Clients. The Adviser provides its services to the Clients as described in the Client’s confidential offering memorandum and governing documents or applicable investment management agreement. Parkman’s investment strategy aims to protect and grow capital by taking long and short positions in a portfolio that consists primarily of a broad range of global equities, focusing on the healthcare sector. Parkman uses a fundamental bottom-up analysis to identify what it considers to be undervalued investments and to capture fundamental valuation

disparities. C. While each of its Clients follow the general strategy mentioned above, the Adviser may tailor the specific advisory services with respect to the individual needs of such Clients pursuant to the agreed upon terms described in the applicable governing documents, including but not limited to an investment management agreement (referred to collectively as “Offering Documents”). Each advisory agreement was separately negotiated and designed to suit the needs of the respective Client and its respective investment guidelines. Such advisory agreements may impose restrictions on Parkman’s ability to invest in certain securities or types of securities. Additional portfolio restrictions may also include exposure limits, concentration limits, industry and sector limits, geographical limits and liquidity limits. D. The Adviser will not participate in wrap fee programs. E. As of December 31, 2023, the Adviser managed $942,517,802 in regulatory assets under management on a discretionary basis. Parkman does not manage any advisory client assets on a non-discretionary basis. 1 As a registered investment adviser, the Adviser owes a fiduciary duty to all of its clients. In 2006, the decision by the Court of Appeals for the D.C. Circuit in Goldstein v. SEC, 451 F.3d 873 (D.C. Cir. June 23, 2006), with respect to private funds, clarified that the “client” of an investment adviser to a private fund is the fund itself and not an investor in the fund.

Revenue	{{ Info.Revenue \| formatUSD }}
Headquarters	{{ Info.Headquarters }}

PARKMAN HEALTHCARE PARTNERS LLC

Adviser Profile

Details

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview